Careers

Diversity

With 18 offices, from New York to Los Angeles and Seattle to Orlando, we live and work in communities all over the U.S., collaborating across locations, disciplines and even borders. Our experienced, highly ranked lawyers serve businesses wherever they are and wherever they want to go.

Offices

About Us

Pages

Professionals

Thought leadership: blogs, podcasts, videos, publications, events and news

Insights

Services

Pro Bono

Am Law 100 firm with practices in Business, Digital Assets and Data Management, Intellectual Property, Labor & Employment, Litigation and Tax.

Home | BakerHostetler

Trump Administration Releases New Guidance on Unlawful DEI

BakerHostetler Joins NATO-DIANA’s Legal Connect

Analysis of Estate Planning and Individual Tax Changes Under the 2025 Tax Legislation

BakerHostetler Team Represents Indiegogo in Acquisition by Gamefound

<p>Stephanie’s practice centers on life sciences patent prosecution, with a particular emphasis on small molecule therapeutics, drug repositioning, antibody-drug conjugates and isotopically labeled pharmaceuticals. She is highly skilled in freedom-to-operate (FTO) analyses, patent landscape evaluations, 505(b)(2) product protection, IP due diligence, portfolio development, post-grant proceedings PTAB appeals and regulatory aligned IP strategies, including Orange Book listings and Patent Term Extension Application. Stephanie’s Ph.D. in synthetic organic chemistry and prior experience as a research chemist brings deep scientific insight and technical fluency to her legal practice, especially in terms of aligning commercial goals with regulatory pathways. Her work has supported the protection and commercialization of numerous FDA-approved products, including Amyvid®, Austedo®, Bendeka®, Ekterly®, Erleada®, Impoyz®, Olysio®, Prezista®, Treanda® and Uzedy®.</p>

core/freeform

core/paragraph

J.D., Rutgers University School of Law, Camden, 2005, 

Ph.D., Organic Chemistry, University of Pennsylvania, 2000, 

B.A., Chemistry, Rutgers University, 1995, 

<ul>
<li>The Legal 500 United States
<ul>
<li>Intellectual Property: Patents: Prosecution (including re-examination and post-grant proceedings) (2022, 2024 to 2025)</li>
</ul>
</li>
<li>Regulatory Affairs Certificate: Medical Devices and Pharmaceuticals</li>
<li>IAM Patent 1000: The World’s Leading Patent Practitioners
<ul>
<li>Pennsylvania: Recommended for Patent Prosecution (2023 to 2025)</li>
</ul>
</li>
<li>Chambers USA: Intellectual Property in Pennsylvania
<ul>
<li>Band 3 (2023 to 2025), Band 4 (2020 to 2022)</li>
</ul>
</li>
<li>Pennsylvania Super Lawyers &#8220;Rising Star&#8221; (2011 to 2012, 2014 to 2015)</li>
<li>Co-Recipient of the 2011 Thomas Alva Edison Patent Award in the Pharmaceuticals category</li>
</ul>


Philadelphia

BakerHostetler attorneys and practice areas spotlighted in the 2025 Legal 500 annual guide

Chambers USA Guide 2025 Recognizes 171 BakerHostetler Attorneys and 73 Practice Areas

BakerHostetler attorneys, practice areas stand out in The Legal 500 annual guide

Chambers USA Guide 2024 Recognizes 155 BakerHostetler Attorneys and ­66 Practice Areas

Chambers USA Guide 2023 Honors 147 BakerHostetler Attorneys and Recognizes 64 Practice Areas

IP Intelligence Report

World IP Day

BakerHostetler Attorneys, Practice Areas Shine in The Legal 500 2022 Guide

Chambers USA Guide 2022 Honors 145 BakerHostetler Attorneys and Recognizes 62 Practice Areas

Stephanie Lodise Explains How U.S. Patent Law Reaches beyond Borders

BakerHosts

Navigating the Fine Line Between Obviousness and Obviousness-Type Double Patenting

Podcast: Navigating the Fine Line Between Obviousness and Obviousness-Type Double Patenting

Promoting the Progress of Science

Promoting the Progress of Science: Written Description and Enablement

Promoting the Progress of Science: Avoiding Inherent Obviousness

Promoting the Progress of Science: Avoiding Inherent Anticipation

Promoting the Progress of Science: How Clinical Stage Patent Strategies Can Bring New Pharmaceuticals to Market

Intellectual Property

IP Life Sciences and Advanced Materials

Industries

Life Sciences

Patent Prosecution

<ul>
<li>Prosecutes, manages and advises on U.S. and international patent portfolios encompassing oncological, antiviral, antibacterial and radio-labeled pharmaceuticals.</li>
<li>Prosecutes, manages and advises on U.S. and international patent portfolios encompassing isotopically labeled small molecules.</li>
<li>Prosecutes, manages and advises on U.S. and international patent portfolios encompassing drug repositioning technologies.</li>
<li>Prosecutes reissue and <em>ex parte</em> reexamination applications for small molecule pharmaceutical compounds.</li>
<li>Advises on patent portfolio development and preservation for commercially marketed pharmaceuticals, including Amyvid®, Austedo®, Bendeka®, Erleada®, Impoyz®, Olysio®, Prezista® and Treanda®.</li>
<li>Prepares and argues appeals to the Patent Trial and Appeal Board.</li>
<li>Advises on patent portfolio development and preservation for 505(b)(2) products.</li>
<li>Creates and develops patent portfolios for pharmaceutical startup companies, creating assets critical in obtaining capital investments.</li>
<li>Provides analysis and advice regarding patent landscapes in various therapeutic areas.</li>
<li>Provides advice and performs freedom-to-operate assessments in support of due diligence analyses for small molecule pharmaceuticals, medical devices and polymers.</li>
<li>Provides advice and performs freedom-to-operate assessments in support of due diligence analyses for dermatological and transdermal compositions.</li>
<li>Advises on and prepares applications for Patent Term Extensions.</li>
<li>Advises on Orange Book listings.</li>
<li>Provides advice on the impact of the judicially created doctrine of obviousness-type double patenting on pharmaceutical patent portfolios.</li>
</ul>


Stephanie A. Lodise, Ph.D.

Stephanie A. Lodise, Ph.D.

Experience

Recognitions and Memberships

Insights and News

Credentials

Community and Pro Bono

Areas of Focus

Industries

Services

Featured Insights